Invesco
CDLX icon

Invesco’s Cardlytics CDLX Stock Holding History

Invesco’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.1K Sell
15,617
-1,584
-9% -$11.8K ﹤0.01% 3770
2026
Q1 		$181K Buy
17,201
+189
+1% +$1.84K ﹤0.01% 3510
2025
Q4 		$196K Buy
17,012
+4,697
+38% +$72.5K ﹤0.01% 3536
2025
Q3 		$299K Buy
12,315
+2,267
+23% +$37.8K ﹤0.01% 3419
2025
Q2 		$165K Buy
10,048
+343
+4% +$5.92K ﹤0.01% 3566
2025
Q1 		$177K Buy
9,705
+2,473
+34% +$70.6K ﹤0.01% 3542
2024
Q4 		$268K Sell
7,232
-5
-0.1% -$191 ﹤0.01% 3449
2024
Q3 		$232K Buy
7,237
+49
+0.7% +$2.72K ﹤0.01% 3486
2024
Q2 		$590K Sell
7,188
-62,084
-90% -$6.71M ﹤0.01% 3206
2024
Q1 		$10M Buy
69,272
+55,221
+393% +$4.66M ﹤0.01% 1814
2023
Q4 		$1.29M Sell
14,051
-66,273
-83% -$6.74M ﹤0.01% 2783
2023
Q3 		$13.3M Buy
80,324
+67,735
+538% +$8.8M ﹤0.01% 1581
2023
Q2 		$796K Sell
12,589
-58
-0.5% -$3.51K ﹤0.01% 2998
2023
Q1 		$429K Buy
12,647
+10,912
+629% +$570K ﹤0.01% 3346
2022
Q4 		$100K Buy
1,735
+9
+0.5% +$556 ﹤0.01% 3825
2022
Q3 		$162K Sell
1,726
-27
-2% -$3.84K ﹤0.01% 3739
2022
Q2 		$391K Sell
1,753
-65
-4% -$21.8K ﹤0.01% 3450
2022
Q1 		$1M Buy
1,818
+252
+16% +$152K ﹤0.01% 3073
2021
Q4 		$1.03M Sell
1,566
-19
-1% -$14.5K ﹤0.01% 3049
2021
Q3 		$1.33M Buy
1,585
+265
+20% +$269K ﹤0.01% 2988
2021
Q2 		$1.68M Sell
1,320
-5,382
-80% -$6.07M ﹤0.01% 2918
2021
Q1 		$7.35M Sell
6,702
-293
-4% -$387K ﹤0.01% 2152
2020
Q4 		$9.99M Buy
+6,995
New +$7.46M ﹤0.01% 1812
2020
Q3 		– Sell
-1,425
Closed -$997K – 3630
2020
Q2 		$997K Sell
1,425
-230
-14% -$133K ﹤0.01% 2801
2020
Q1 		$579K Sell
1,655
-11,527
-87% -$8.16M ﹤0.01% 2994
2019
Q4 		$8.29M Sell
13,182
-3,124
-19% -$1.53M ﹤0.01% 1877
2019
Q3 		$5.47M Buy
16,306
+12,228
+300% +$3.92M ﹤0.01% 2083
2019
Q2 		$1.06M Buy
+4,078
New +$817K ﹤0.01% 3040

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Invesco's CDLX Position: Q2 2026 in Review

Invesco reduced its Cardlytics (CDLX) stake by 9.2% in Q2 2026, selling an estimated $11.8K and leaving 15,617 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Invesco first reported a position in CDLX in Q2 2019 and has held it in 28 quarters since. The position peaked at $13.3M in Q3 2023. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Invesco held 15,617 shares of Cardlytics worth $70.1K as of Q2 2026.
  • Invesco sold 1,584 Cardlytics shares in Q2 2026, an estimated $11.8K.
  • Cardlytics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3770 holding.
  • Invesco first reported a position in Cardlytics in Q2 2019 and has held it in 28 quarters since.
  • Invesco's Cardlytics position peaked at $13.3M in Q3 2023.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.